Report
Dr. Michael Green

Obtala - Forecasts and DCF model update

  • Forecasts updated following Q4 statement and talks with management

    At the top line, for 2017 we have pared back our forecasts for the agriculture division due to the slower than expected year, which was affected by prolonged rains. We also modestly reduce forecasts in the forestry production and trading businesses. The overall effect is to reduce group revenue forecasts for 2017 from $10.2 million to $9.4 million. Due to higher costs we now expect an underlying pre-tax loss (excluding the gain made on the purchase of Woodbois) of $5.8 million, up from $0.3 million.

    For 2018 we also pare back our revenue forecasts across the divisions and look for $41 million at the group level, down from $45.9 million. Higher costs and investments take pre-tax profits down from $20.8 million previously to $7.1 million. We also update our model for the recent strengthening of sterling against the US dollar. Our forecasts for 2019 and beyond, used in the DCF analysis, are unchanged.

  • Despite the revision our target price only falls from 38.18p to 38.09p

    This is due to the lower forecast profits and negative exchange rate movements being offset by removing the loss making 2017 numbers from the DCF analysis and by adding additional funds received from preference share issues in H2 2017.

  • Shares now offering 185% potential upside following a recent pullback

    Currently trading at 13.375p, a c.15 month low, Obtala shares look significantly undervalued. Our DCF derived target implies upside of 185%. In addition, the recent preference share issues by subsidiary Argento value Obtala’s effective 57% stake at c.£44 million (c.15p per share). This is 12% above the current market cap and effectively values the acquired Woodbois business and agriculture operations at less than zero. We retain our Conviction Buy stance and look forward to seeing further progress across the three divisions over the current financial year.

Provider
Align Research
Align Research

Align Research is a commissioned research company founded in November 2015 in order to provide the under-served smaller company space with high quality analysis. We have an initial focus on the natural resources sector, in which we see significant opportunities given the current once in a generation bear market, however all undervalued small caps (sub £100m) are considered by our team. Align was founded by industry professionals with decades of experience in the stock markets, headed up by highly qualified individuals from both fund management and analytical backgrounds.

Analysts
Dr. Michael Green

Other Reports from Align Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch